Contract 75N93022C00023
Fisher Bioservices Inc · Department Of Health And Human Services · August 27, 2024
Fisher Bioservices Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 27, 2024 for $5.89 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Rockville, MD. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $17.09 million.
Contract details
- PIID
- 75N93022C00023
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Rockville, MD
- First action
- August 27, 2024
Description
ADMINISTRATIVE ACTION
Modification timeline
-
August 27, 2024Mod P00003 · Exercise An Option$17.09M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93022C00023?
Contract 75N93022C00023 is a federal contract awarded to Fisher Bioservices Inc by Department Of Health And Human Services on August 27, 2024 for $5.89 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75N93022C00023?
Fisher Bioservices Inc won contract 75N93022C00023 from Department Of Health And Human Services.
How much is contract 75N93022C00023 worth?
Contract 75N93022C00023 has obligated $5.89 million to date, with a total potential value of $17.09 million if all options are exercised.